These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 15128010)
21. Groin Recurrences in Node Negative Vulvar Cancer Patients After Sole Sentinel Lymph Node Dissection. Klapdor R; Hertel H; Soergel P; Hillemanns P Int J Gynecol Cancer; 2017 Jan; 27(1):166-170. PubMed ID: 27870709 [TBL] [Abstract][Full Text] [Related]
22. Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block. Dusenbery KE; Carlson JW; LaPorte RM; Unger JA; Goswitz JJ; Roback DM; Fowler JM; Adcock LL; Carson LF; Potish RA Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):989-98. PubMed ID: 8083101 [TBL] [Abstract][Full Text] [Related]
23. Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer. Johann S; Klaeser B; Krause T; Mueller MD Gynecol Oncol; 2008 Sep; 110(3):324-8. PubMed ID: 18582920 [TBL] [Abstract][Full Text] [Related]
24. Groin surgery and the sentinel lymph node. de Hullu JA; van der Zee AG Best Pract Res Clin Obstet Gynaecol; 2003 Aug; 17(4):571-89. PubMed ID: 12965133 [TBL] [Abstract][Full Text] [Related]
25. Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature. Makar AP; Scheistroen M; van den Weyngaert D; Tropé CG Int J Gynecol Cancer; 2001; 11(4):255-62. PubMed ID: 11520362 [TBL] [Abstract][Full Text] [Related]
26. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Moore RG; Robison K; Brown AK; DiSilvestro P; Steinhoff M; Noto R; Brard L; Granai CO Gynecol Oncol; 2008 Apr; 109(1):65-70. PubMed ID: 18255128 [TBL] [Abstract][Full Text] [Related]
27. Pathological process has a crucial role in sentinel node biopsy for vulvar cancer. Sykes P; Eva L; van der Griend R; McNally O; Blomfield P; Brand A; Tristram A; Bergzoll C; Petrich S; Kenwright D; Payne K; Kellow M; Innes C; Harker D; Perrin L; Cohen P; Jaaback K; Simcock B Gynecol Oncol; 2019 May; 153(2):292-296. PubMed ID: 30814024 [TBL] [Abstract][Full Text] [Related]
28. Sentinel node biopsy in vulvar cancer: Implications for staging. Oonk MH; Hollema H; van der Zee AG Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):812-21. PubMed ID: 25962357 [TBL] [Abstract][Full Text] [Related]
29. Management of squamous cell vulvar cancer: a review. Deppe G; Mert I; Winer IS J Obstet Gynaecol Res; 2014 May; 40(5):1217-25. PubMed ID: 24750413 [TBL] [Abstract][Full Text] [Related]
30. [The incidence of human papilloma virus associated vulvar cancer in younger women is increasing and wide local excision with sentinel lymph node biopsie has become standard]. Fehr MK Ther Umsch; 2011 Oct; 68(10):537-43. PubMed ID: 21968892 [TBL] [Abstract][Full Text] [Related]
31. Update on the sentinel lymph node procedure in vulvar cancer. Oonk MH; van de Nieuwenhof HP; van der Zee AG; de Hullu JA Expert Rev Anticancer Ther; 2010 Jan; 10(1):61-9. PubMed ID: 20014886 [TBL] [Abstract][Full Text] [Related]
32. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection. Fonseca-Moutinho JA; Coelho MC; Silva DP J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review. Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM Gynecol Oncol; 2018 Mar; 148(3):622-631. PubMed ID: 29137809 [TBL] [Abstract][Full Text] [Related]
34. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Lupi G; Raspagliesi F; Zucali R; Fontanelli R; Paladini D; Kenda R; di Re F Cancer; 1996 Apr; 77(8):1472-8. PubMed ID: 8608531 [TBL] [Abstract][Full Text] [Related]
35. Midline involvement as a risk factor for vulvar cancer recurrence. Stankevica J; Macuks R; Baidekalna I; Donina S Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment options of vulvar cancer: a review. Dittmer C; Fischer D; Diedrich K; Thill M Arch Gynecol Obstet; 2012 Jan; 285(1):183-93. PubMed ID: 21909752 [TBL] [Abstract][Full Text] [Related]
37. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers. Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604 [TBL] [Abstract][Full Text] [Related]
38. Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis. McCann GA; Cohn DE; Jewell EL; Havrilesky LJ Gynecol Oncol; 2015 Feb; 136(2):300-4. PubMed ID: 25478927 [TBL] [Abstract][Full Text] [Related]